158 related articles for article (PubMed ID: 38468628)
1. Prevalence, incidence, and medications of narcolepsy in Japan: a descriptive observational study using a health insurance claims database.
Imanishi A; Kamada Y; Shibata K; Sakata Y; Munakata H; Ishii M
Sleep Biol Rhythms; 2022 Oct; 20(4):585-594. PubMed ID: 38468628
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and incidence of narcolepsy in a US health care claims database, 2008-2010.
Scheer D; Schwartz SW; Parr M; Zgibor J; Sanchez-Anguiano A; Rajaram L
Sleep; 2019 Jul; 42(7):. PubMed ID: 31004158
[TBL] [Abstract][Full Text] [Related]
3. Correction to: Prevalence, incidence, and medications of narcolepsy in Japan: a descriptive observational study using a health insurance claims database.
Imanishi A; Kamada Y; Shibata K; Sakata Y; Munakata H; Ishii M
Sleep Biol Rhythms; 2023 Jan; 21(1):127. PubMed ID: 38468902
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, incidence, and health care utilization of patients with narcolepsy: a population-representative study.
Kallweit U; Nilius G; Trümper D; Vogelmann T; Schubert T
J Clin Sleep Med; 2022 Jun; 18(6):1531-1537. PubMed ID: 35088707
[TBL] [Abstract][Full Text] [Related]
5. Burden of narcolepsy in Japan: A health claims database study evaluating direct medical costs and comorbidities.
Kamada Y; Imanishi A; Chiu SW; Yamaguchi T
Sleep Med; 2024 Feb; 114():119-127. PubMed ID: 38181583
[TBL] [Abstract][Full Text] [Related]
6. Incidence and prevalence of primary care antidepressant prescribing in children and young people in England, 1998-2017: A population-based cohort study.
Jack RH; Hollis C; Coupland C; Morriss R; Knaggs RD; Butler D; Cipriani A; Cortese S; Hippisley-Cox J
PLoS Med; 2020 Jul; 17(7):e1003215. PubMed ID: 32697803
[TBL] [Abstract][Full Text] [Related]
7. Clinical and therapeutic aspects of childhood narcolepsy-cataplexy: a retrospective study of 51 children.
Aran A; Einen M; Lin L; Plazzi G; Nishino S; Mignot E
Sleep; 2010 Nov; 33(11):1457-64. PubMed ID: 21102987
[TBL] [Abstract][Full Text] [Related]
8. Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy.
Szabo ST; Thorpy MJ; Mayer G; Peever JH; Kilduff TS
Sleep Med Rev; 2019 Feb; 43():23-36. PubMed ID: 30503715
[TBL] [Abstract][Full Text] [Related]
9. Bupropion is effective in depression in narcolepsy.
Goksan B; Mercan S; Karamustafalioglu O
Int J Psychiatry Clin Pract; 2005; 9(4):289-91. PubMed ID: 24930928
[TBL] [Abstract][Full Text] [Related]
10. Incidence and Prevalence of Epilepsy in Japan: A Retrospective Analysis of Insurance Claims Data of 9,864,278 Insured Persons.
Kurisu A; Sugiyama A; Akita T; Takumi I; Yamamoto H; Iida K; Tanaka J
J Epidemiol; 2024 Feb; 34(2):70-75. PubMed ID: 36843107
[TBL] [Abstract][Full Text] [Related]
11. Update on the pharmacologic management of narcolepsy: mechanisms of action and clinical implications.
Thorpy MJ; Bogan RK
Sleep Med; 2020 Apr; 68():97-109. PubMed ID: 32032921
[TBL] [Abstract][Full Text] [Related]
12. Treatment of narcolepsy and other hypersomnias of central origin.
Wise MS; Arand DL; Auger RR; Brooks SN; Watson NF;
Sleep; 2007 Dec; 30(12):1712-27. PubMed ID: 18246981
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic advances in narcolepsy.
Thorpy M
Sleep Med; 2007 Jun; 8(4):427-40. PubMed ID: 17475553
[TBL] [Abstract][Full Text] [Related]
14. Treatment modalities for narcolepsy.
Fry JM
Neurology; 1998 Feb; 50(2 Suppl 1):S43-8. PubMed ID: 9484423
[TBL] [Abstract][Full Text] [Related]
15. Comorbidity of Narcolepsy and Psychotic Disorders: A Nationwide Population-Based Study in Taiwan.
Yeh JY; Shyu YC; Lee SY; Yuan SS; Yang CJ; Yang KC; Lee TL; Sun CC; Wang LJ
Front Psychiatry; 2020; 11():205. PubMed ID: 32269533
[TBL] [Abstract][Full Text] [Related]
16. Incidence of interventions for diabetic retinopathy and serious lower-limb complications and its related factors in patients with type 2 diabetes using a real-world large claims database.
Yanagisawa-Sugita A; Sugiyama T; Ihana-Sugiyama N; Tanaka H; Imai K; Ueki K; Ohsugi M; Tamiya N; Kobayashi Y
Diabetol Int; 2022 Jul; 13(3):548-560. PubMed ID: 35693997
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of modafinil for improving daytime wakefulness in patients treated previously with psychostimulants.
Schwartz JR; Feldman NT; Fry JM; Harsh J
Sleep Med; 2003 Jan; 4(1):43-9. PubMed ID: 14592359
[TBL] [Abstract][Full Text] [Related]
18. Compliance with stimulant medications in patients with narcolepsy.
Rogers AE; Aldrich MS; Berrios AM; Rosenberg RS
Sleep; 1997 Jan; 20(1):28-33. PubMed ID: 9130331
[TBL] [Abstract][Full Text] [Related]
19. Narcolepsy: current treatment options and future approaches.
Billiard M
Neuropsychiatr Dis Treat; 2008 Jun; 4(3):557-66. PubMed ID: 18830438
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of patients with lymphangioleiomyomatosis: A descriptive study using the national database of health insurance claims and specific health checkups of Japan.
Kimura Y; Jo T; Hashimoto Y; Kumazawa R; Ishimaru M; Matsui H; Yokoyama A; Tanaka G; Yasunaga H
Respir Investig; 2024 May; 62(3):494-502. PubMed ID: 38583226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
